COMMERCE & FINANCIAL INSTITUTIONS COMMITTEE
TECHNOLOGY, BIOSCIENCE & MEDICAL PRODUCTS DIVISION
MINUTES
Representative Paul Kohls, Chair of the Technology, Bioscience & Medical Products Division, called the FIFTH meeting to order at 12:35 p.m. on Thursday, March 3, 2005, in Room 200 of the State Office Building.
The Clerk noted the roll.
Members present:
KOHLS, Paul, Chair
DAVIDS, Greg
HAMILTON, Rod
PEPPIN, Joyce
SEVERSON, Dan
ZELLERS, Kurt
FRITZ, Patti
GOODWIN, Barb
LIEBLING, Tina
LOEFFLER, Diane
MULLERY, Joe
Members excused:
A quorum was present.
Rep. Zellers moved the adoption of the minutes of the Technology, Bioscience & Medical Products Division Committee dated Thursday, February 24, 2005
THE MOTION PREVAILED
Rep. Peppin assumed the gavel at 12:35
HF 1356 (Kohls) Corporate research tax credit computation increased
Rep. Kohls moved that HF 1356 be recommended to pass and be considered by the Commerce and Financial Institutions committee.
THE MOTION PREVAILED
The following individuals testified on HF 1356:
Phil Griffin, Medical Alley
John Zentgraf, VP R&D, Cardiac Rhythm Management
Darrel Gubrud, President, Gubrud Consulting
Rep. Kohls resumed the gavel at 1:45
HF 1127 (Brod) Biotechnology and health sciences industry zone tax credit amount increased
Rep. Kohls moved that HF 1127 be recommended to pass and be considered by the Commerce and Financial Institutions committee.
THE MOTION PREVAILED
The following individual testified on HF 1127:
Gene Goddard, DEED
HF 1357 (Peppin) Corporate research tax credit increased, and money appropriated for the biotechnology credit
Rep. Peppin moved HF 1357 be recommended to pass and be considered by the Commerce and Financial Institutions committee.
THE MOTION PREVAILED
The following individual testified on HF 1357:
Charles Halstenson, Prism Research
The meeting was adjourned at 2:20
REP. PAUL KOHLS, CHAIR
Veronica I. Garcia
Committee Legislative Assistant